市场调查报告书
商品编码
1305213
全球生药市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测Global Eubiotics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
在2023-2030年的研究期内,预计全球生药市场需求将从2022年的81.2亿美元增长到2030年的近169.9亿美元,复合年增长率为8.55%。在产量方面,2022年的市场容量为XX个单位,预计到2030年将达到XX个单位,2023-2030年的复合年增长率为XX%。
Eubiotics是用于描述促进动物消化系统微生物平衡和健康的物质或技术的术语。它是指使用饲料添加剂,如益生菌、益生元、有机酸和酶来改善动物的健康和性能。在畜牧业中使用益生菌可减少饲料中抗生素和其他化学添加剂的使用,因为它们提供了一种天然、安全的替代品。它们还可用于改善动物健康、福利和生产力,以及减少疾病的发生和兽医干预的需要。
全球对肉类和动物产品的需求不断增长,推动了动物饲料中对生物素的需求。生物素有助于改善动物健康和提高生产率,从而提高肉类和乳制品的质量和数量。许多国家限制抗生素生长促进剂在动物饲料中的使用,导致越来越多地使用生物素作为天然替代品来改善动物健康和提高动物性能。消费者和动物福利组织对抗生素在动物饲料中的使用及其对动物健康和福利的潜在影响的认识不断提高,推动了对生物素的需求。人们对食品安全和质量的日益关注推动了动物饲料中生物素的需求。生物素被认为是抗生素的安全天然替代品,使用生物素可提高肉类和动物产品的质量和安全性。微胶囊技术和纳米技术等新型先进生物素生产技术的发展推动了生物素市场的增长。中国、印度和巴西等经济不断增长的国家对肉类和动物产品的需求不断增加,推动了动物饲料中益生元的需求。这些地区不断增长的需求预计将在未来几年推动全球动物营养素市场的增长。
本报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于在全球范围内清晰地了解行业结构并评估竞争吸引力。此外,这些工具还对全球益生菌市场的各个细分市场进行了全面评估。保健食品行业的增长和趋势为本研究提供了全面的方法。
本部分通过分析国家和地区层面的细分市场提供详细数据,从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。
本部分涵盖了区域前景,突出了北美、欧洲、亚太、拉美、中东和非洲地区对益生元市场当前和未来的需求。此外,报告还重点分析了所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场中主要企业的综合概况以及全球竞争格局的深入分析。益生菌市场的主要参与者包括DSM、Novozymes、Kemin Industries Inc.、Roquette Freres、FrieslandCampina、Neospark Drugs and Chemicals Private Limited、ASAHI GROUP HOLDINGS Ltd.、Lesaffre、MSPrebiotics Inc.、ADM、Lallemand Inc.、BEHN MEYER、NOVUS INTERNATIONAL、BENEO、Yara、Cargill Incorporated、BASF SE、Chr. Hansen Holding A/S、ADDCON GmbH。本节包括竞争格局的整体视图,其中包括各种战略发展,如关键并购、未来产能、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。
注-在公司概况中,财务细节和近期发展视情况而定,如果是私营公司则可能不包括在内。
The global demand for Eubiotics Market is presumed to reach the market size of nearly USD 16.99 BN by 2030 from USD 8.12 BN in 2022 with a CAGR of 8.55% under the study period of 2023 - 2030. Regarding volume, the market was calculated XX Units in 2022 and forecast to touch XX Units by 2030 with a CAGR of XX% during 2023 - 2030.
Eubiotics is a term used to describe substances or techniques that promote the balance and well-being of microorganisms in the digestive system of animals. It refers to the use of feed additives, such as probiotics, prebiotics, organic acids, and enzymes, to improve the health and performance of animals. Eubiotics are used in animal husbandry to reduce the use of antibiotics and other chemical additives in feed, as they provide a natural and safe alternative. They are also used to improve animal health, welfare, and productivity, as well as to reduce the incidence of diseases and the need for veterinary interventions.
The growing demand for meat and animal products worldwide is driving the demand for eubiotics in animal feed. Eubiotics help improve animal health and productivity, which leads to better quality and quantity of meat and dairy products. The restriction on antibiotic growth promoters' usage in animal feed in many countries has led to the increased use of eubiotics as a natural alternative to improve animal health and performance. The increasing awareness among consumers and animal welfare organizations about the use of antibiotics in animal feed and its potential impact on animal health and welfare are driving the demand for eubiotics. The rising concerns about food safety and quality are driving the demand for eubiotics in animal feed. Eubiotics are considered safe and natural alternatives to antibiotics, and their use can improve the quality and safety of meat and animal products. The development of new and advanced technologies in the production of eubiotics, such as microencapsulation and nanotechnology, is driving the growth of the eubiotics market. The rising demand for meat and animal products in the growing economies of China, India, and Brazil is driving the demand for eubiotics in animal feed. The increasing demand from these regions is expected to drive the growth of the global eubiotics market in the coming years.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of eubiotics. The growth and trends of Eubiotics Industry provide a holistic approach to this study.
This section of the eubiotics market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Eubiotics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the eubiotics market include DSM, Novozymes, Kemin Industries Inc., Roquette Freres, FrieslandCampina, Neospark Drugs and Chemicals Private Limited, ASAHI GROUP HOLDINGS Ltd., Lesaffre, MSPrebiotics Inc., ADM, Lallemand Inc., BEHN MEYER, NOVUS INTERNATIONAL, BENEO, Yara, Cargill Incorporated, BASF SE, Chr. Hansen Holding A/S, ADDCON GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies